Stryker Total Assets 2010-2025 | SYK

Stryker total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Stryker total assets for the quarter ending March 31, 2025 were $46.006B, a 16.76% increase year-over-year.
  • Stryker total assets for 2024 were $42.971B, a 7.66% increase from 2023.
  • Stryker total assets for 2023 were $39.912B, a 8.21% increase from 2022.
  • Stryker total assets for 2022 were $36.884B, a 6.51% increase from 2021.
Stryker Annual Total Assets
(Millions of US $)
2024 $42,971
2023 $39,912
2022 $36,884
2021 $34,631
2020 $34,330
2019 $30,167
2018 $27,229
2017 $22,197
2016 $20,435
2015 $16,223
2014 $17,279
2013 $15,743
2012 $13,206
2011 $12,146
2010 $10,895
2009 $9,071
Stryker Quarterly Total Assets
(Millions of US $)
2025-03-31 $46,006
2024-12-31 $42,971
2024-09-30 $43,833
2024-06-30 $39,130
2024-03-31 $39,402
2023-12-31 $39,912
2023-09-30 $38,042
2023-06-30 $37,409
2023-03-31 $36,830
2022-12-31 $36,884
2022-09-30 $35,983
2022-06-30 $36,032
2022-03-31 $36,137
2021-12-31 $34,631
2021-09-30 $34,145
2021-06-30 $33,698
2021-03-31 $33,455
2020-12-31 $34,330
2020-09-30 $32,286
2020-06-30 $31,483
2020-03-31 $29,440
2019-12-31 $30,167
2019-09-30 $26,659
2019-06-30 $26,354
2019-03-31 $25,937
2018-12-31 $27,229
2018-09-30 $22,084
2018-06-30 $21,570
2018-03-31 $22,133
2017-12-31 $22,197
2017-09-30 $21,485
2017-06-30 $21,292
2017-03-31 $20,517
2016-12-31 $20,435
2016-09-30 $20,187
2016-06-30 $20,520
2016-03-31 $19,668
2015-12-31 $16,223
2015-09-30 $15,917
2015-06-30 $16,819
2015-03-31 $16,580
2014-12-31 $17,279
2014-09-30 $17,515
2014-06-30 $17,229
2014-03-31 $16,159
2013-12-31 $15,743
2013-09-30 $14,883
2013-06-30 $14,382
2013-03-31 $14,089
2012-12-31 $13,206
2012-09-30 $12,777
2012-06-30 $12,262
2012-03-31 $12,459
2011-12-31 $12,146
2011-09-30 $12,083
2011-06-30 $11,596
2011-03-31 $11,231
2010-12-31 $10,895
2010-09-30 $10,772
2010-06-30 $10,060
2010-03-31 $10,098
2009-12-31 $9,071
2009-09-30 $8,459
2009-06-30 $7,924
2009-03-31 $7,585
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $142.469B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.372B 27.70
Boston Scientific (BSX) United States $149.971B 37.54
EssilorLuxottica (ESLOY) France $128.310B 0.00
Medtronic (MDT) Ireland $109.952B 15.59
Lonza Group Ag (LZAGY) Switzerland $49.265B 0.00
Haleon (HLN) United Kingdom $47.015B 26.80
ResMed (RMD) United States $36.786B 27.63
GE HealthCare Technologies (GEHC) United States $32.917B 15.63
Agilent Technologies (A) United States $32.815B 21.39
Terumo (TRUMY) Japan $26.606B 34.56
Koninklijke Philips (PHG) Netherlands $21.242B 14.90
Insulet (PODD) United States $21.238B 83.37
Zimmer Biomet Holdings (ZBH) United States $17.915B 11.51
Baxter (BAX) United States $15.293B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $12.517B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $9.087B 0.00
Bio-Rad Laboratories (BIO) United States $6.313B 21.97
Lantheus Holdings (LNTH) United States $5.465B 13.78
Prestige Consumer Healthcare (PBH) United States $4.133B 18.46
Perrigo (PRGO) Ireland $3.618B 9.17
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.366B 15.33
ICU Medical (ICUI) United States $3.165B 23.34
Envista Holdings (NVST) United States $3.154B 26.21
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.916B 13.18
LeMaitre Vascular (LMAT) United States $1.846B 41.26
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.335B 0.00
AdaptHealth (AHCO) United States $1.144B 11.62
Neogen (NEOG) United States $1.083B 13.86
Green Thumb Industries (GTBIF) United States $1.059B 23.81
BioLife Solutions (BLFS) United States $1.022B 0.00
Phibro Animal Health (PAHC) United States $0.971B 12.41
InMode (INMD) Israel $0.843B 8.50
Kestra Medical Technologies (KMTS) United States $0.796B 0.00
CeriBell (CBLL) United States $0.643B 0.00
Evolus (EOLS) United States $0.600B 0.00
Owens & Minor (OMI) United States $0.576B 4.78
Curaleaf Holdings (CURLF) Canada $0.547B 0.00
Capricor Therapeutics (CAPR) United States $0.545B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.512B 0.00
Valneva SE (VALN) France $0.487B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.386B 0.00
SNDL (SNDL) Canada $0.334B 0.00
VAREX IMAGING (VREX) United States $0.316B 11.62
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.282B 0.00
Aurora Cannabis (ACB) Canada $0.263B 78.00
Viemed Healthcare (VMD) United States $0.260B 21.93
Cerus (CERS) United States $0.256B 0.00
Quanterix (QTRX) United States $0.248B 0.00
Sanara MedTech (SMTI) United States $0.245B 0.00
ZimVie (ZIMV) United States $0.240B 10.90
Canopy Growth (CGC) Canada $0.237B 0.00
Cresco Labs (CRLBF) United States $0.236B 0.00
Biote (BTMD) United States $0.218B 6.14
OraSure Technologies (OSUR) United States $0.215B 0.00
Brainsway (BWAY) Israel $0.208B 55.15
TriSalus Life Sciences (TLSI) United States $0.204B 0.00
Verano Holdings (VRNOF) United States $0.192B 0.00
Omeros (OMER) United States $0.189B 0.00
High Tide (HITI) Canada $0.178B 0.00
Organigram Global (OGI) Canada $0.177B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.20
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.128B 15.76
Jin Medical (ZJYL) China $0.110B 0.00
Veru (VERU) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.087B 11.25
MacroGenics (MGNX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Agape ATP (ATPC) $0.076B 0.00
Zynex (ZYXI) United States $0.073B 0.00
Cytosorbents (CTSO) United States $0.073B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.055B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Nephros (NEPH) United States $0.038B 51.14
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.032B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00